Confronto

Enfuvirtid vs. Sincalide

Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.

Identità

Categoria

Ricerca (altro)

N. CAS

159519-65-0

25126-32-3

Peso molecolare

4491.88 g/mol

1143.29 g/mol

Emivita

nessun dato

Sequenza

nessun dato

Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2

Meccanismo d'azione

Enfuvirtid

Enfuvirtide binds the first heptad-repeat region (HR1) of the gp41 subunit of the HIV envelope protein. This prevents the conformational change required for fusion of the viral and cell membranes — the virus cannot enter the cell.

Sincalide

Sincalide activates CCK receptors, triggering gallbladder contraction and pancreatic enzyme secretion. This effect is used diagnostically to measure the gallbladder ejection fraction (e.g. in HIDA scintigraphy).

Base di evidenze

Evidenza più alta

RCT sull'uomo

Studio sull'uomo

Studi

di cui sull'uomo

Effetti registrati

Contraddizioni aperte

Eventi avversi documentati

Stato legale

Country	Enfuvirtid	Sincalide
Germania	Su prescrizione	Non chiaro
Stati Uniti	Su prescrizione	Su prescrizione

Voci complete

Frequently asked questions

What is the difference between Enfuvirtid and Sincalide?: Enfuvirtid is classified as "Ricerca (altro)", while Sincalide is classified as "Ricerca (altro)". Enfuvirtid: Enfuvirtide is a synthetic 36-amino-acid peptide and the first HIV-1 fusion inhibitor. It binds the HR1 region of the viral envelope protein gp41, blocking viral entry into the cell. Approved for treatment-experienced HIV patients. Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Enfuvirtid or Sincalide?: The highest available evidence level is "RCT sull'uomo" for Enfuvirtid and "Studio sull'uomo" for Sincalide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Enfuvirtid and Sincalide in Germany and the United States?: Germania: Enfuvirtid — Su prescrizione, Sincalide — Non chiaro. Stati Uniti: Enfuvirtid — Su prescrizione, Sincalide — Su prescrizione. These are factual summaries with source and review date on the individual pages.

Country

Enfuvirtid

Sincalide

Germania

Su prescrizione

Non chiaro

Stati Uniti

Su prescrizione

Frequently asked questions

What is the difference between Enfuvirtid and Sincalide?

Enfuvirtid is classified as "Ricerca (altro)", while Sincalide is classified as "Ricerca (altro)". Enfuvirtid: Enfuvirtide is a synthetic 36-amino-acid peptide and the first HIV-1 fusion inhibitor. It binds the HR1 region of the viral envelope protein gp41, blocking viral entry into the cell. Approved for treatment-experienced HIV patients. Sincalide: Sincalide is the synthetic C-terminal octapeptide of the hormone cholecystokinin (CCK-8). As Kinevac it is FDA-approved to stimulate gallbladder contraction for diagnostic imaging. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Enfuvirtid or Sincalide?

The highest available evidence level is "RCT sull'uomo" for Enfuvirtid and "Studio sull'uomo" for Sincalide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Enfuvirtid and Sincalide in Germany and the United States?

Germania: Enfuvirtid — Su prescrizione, Sincalide — Non chiaro. Stati Uniti: Enfuvirtid — Su prescrizione, Sincalide — Su prescrizione. These are factual summaries with source and review date on the individual pages.